Daniel Gonzalez, PharmD, PhD

Associate Professor in Medicine
Duke University School of Medicine

Disclosure(s): Melinta Therapeutics, LLC: Advisor/Consultant; Nabriva Therapeutics plc: Grant/Research Support; Simulations Plus, Inc.: Advisor/Consultant

Poster(s):

• (P-1222) Oral Cephalexin Population Pharmacokinetics and Target Attainment Analysis in Infants 0-60 Days Old
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT